Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia
Work
Year: 2017
Type: article
Source: Blood
Authors Eytan M. Stein, Courtney D. DiNardo, Daniel A. Pollyea, Amir T. Fathi, Gail J. Roboz +22 more
Institutions Memorial Sloan Kettering Cancer Center, Cornell University, The University of Texas MD Anderson Cancer Center, University of Colorado Denver, Massachusetts General Hospital +18 more
Cites: 35
Cited by: 1,313
Related to: 10
FWCI: 120.2
Citation percentile (by year/subfield): 99.99
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: bronze